Tokyo may raise COVID-19 alert to highest on Thursday amid virus spike - Reports
Moscow/Sputnik: The Tokyo metropolitan government intends to update the COVID-19 alert to the highest level amid a record rise in cases both in the capital and nationwide, the Kyodo news agency reported on Wednesday, citing knowledgeable sources.
Pfizer COVID-19 vaccine emerges 95 percent effective in final analysis
Washington: Pharmaceutical major Pfizer on Wednesday confirmed that its COVID-19 vaccine candidate is 95 percent effective in the final analysis of the Phase 3 trial.
Bangladesh registers 21 COVID-19 deaths in 24 hours
Dhaka: Bangladesh registered 21 COVID-19 deaths in the past 24 hours, media reports said on Wednesday.
New coronavirus recoveries outpace daily new cases for more than 1.5 months
New Delhi/UNI: New Covid-19 recoveries on Wednesday outpaced daily new additions for more than 1.5 months, as less than 50,000 new daily cases surfaced for the eleventh continuous day.
Turmeric lozenge to help reduce Coroanvirus infection risk: Study
Mumbai/UNI: A Mumbai based KJ Somaiya Hospital and Gelnova Labs have taken a step towards minimising the infection risk of Covid-19 amongst health care workers by following a month-long study with 303 healthcare workers to study the role of Turmgel in reducing the risk of infection.
COVID-19: Bengaluru fatality rate lowest among major cities, says Minister
Bengaluru/UNI: Bengaluru's Covid-19 fatality rate (1.1 per cent) is the lowest among all major cities in the country, Karnataka Minister for Health Dr K Sudhakar said on Wednesday.
Additional doctors, ICU beds, testing facilities to contain spike in Coroanvirus cases in Delhi: MHA
New Delhi/UNI: Around 45 doctors and 160 paramedics from Central Armed police Force (CAPF) will soon take over the management of the DRDO-run Covid care hospital near Delhi airport, Union Home Ministry officials said here on Wednesday.
WHO regional department in DR Congo says 11th outbreak of Ebola virus defeated
Moscow/Sputnik: DR Congo has overcome the eleventh outbreak of the Ebola virus, which had been circulating for half a year in the Central African nation, the World Health Organization (WHO) regional department announced on Wednesday.
Pakistan continues to witness spike in Coronavirus cases, registers 2298 new cases
Islamabad: Pakistan is witnessing yet another spike in COVID-19 cases as 2,298 new coronavirus cases were registered on Nov 17.
Kuwait to receive 1.7 million doses of Moderna Coronavirus vaccine: Reports
Doha/Sputnik: Kuwait has signed a contract with US company Moderna to receive 1.7 million doses of the COVID-19 vaccine after production begins, Kuwaiti newspaper Al Rai reported.
India registers over 38,000 COVID-19 cases in past 24 hours
New Delhi: After maintaining less than 30,000 cases for the past two days, India on Wednesday recorded 38,617 new COVID-19 cases in the past 24 hours, as per Ministry of Health data released.
New partnership to boost maternal and newborn health in East and Southern Africa
New York: Some 10,000 health workers will be trained to support mothers and newborns in Africa through a partnership between the UN Children’s Fund, UNICEF, and Laerdal Global Health, the non-profit arm of a Norwegian company that provides innovative training, educational and therapy solutions for emergency medical care and patient safety.
‘Full scale’ humanitarian crisis unfolding in Ethiopia’s Tigray: UNHCR
New York: A “full-scale humanitarian crisis” is unfolding as thousands of refugees flee ongoing fighting in Ethiopia’s Tigray region each day to seek safety in eastern Sudan, the UN refugee agency (UNHCR) reported on Tuesday.
WHO rolls out plan to rid world of cervical cancer, saving millions of lives
New York: The World Health Organization (WHO) set out a strategy on Tuesday for eliminating cervical cancer, which would avoid the death of an estimated five million women and girls from the disease, by 2050.
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today in The Lancet Infectious Diseases journal, finding the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years.